Cargando…

Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines

Detalles Bibliográficos
Autor principal:	Kelso, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837118/ https://www.ncbi.nlm.nih.gov/pubmed/33441235 http://dx.doi.org/10.1016/j.vaccine.2020.12.084

Ejemplares similares

Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study
por: Hatziantoniou, Sophia, et al.
Publicado: (2021)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

Immediate reactions after mRNA SARS-CoV-2 vaccination
por: Jeimy, Samira, et al.
Publicado: (2021)

Diagnosis of Acute Myocarditis Following mRNA Vaccines against SARS-CoV-2: A Methodological Review
por: Zuin, Marco, et al.
Publicado: (2023)

Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis
por: Alhumaid, Saad, et al.
Publicado: (2021)

Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines
por: Kelso, John M.
Publicado: (2021)

Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2: does one size fit all?
por: Tau, Noam, et al.
Publicado: (2021)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis
por: Martin, Paul, et al.
Publicado: (2021)

Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
por: Blumenthal, Kimberly G., et al.
Publicado: (2021)

Delayed Hypersensitivity Reactions Following First Dose of the SARS-CoV2 mRNA Vaccines
por: Xu, Jennifer, et al.
Publicado: (2021)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration
por: Desai, Aditya P., et al.
Publicado: (2021)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
por: Jackson, Lisa A., et al.
Publicado: (2020)

A novel mRNA vaccine, SYS6006, against SARS-CoV-2
por: Xu, Ke, et al.
Publicado: (2023)

A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
por: Pettini, Elena, et al.
Publicado: (2022)

mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients
por: Albiol, Nil, et al.
Publicado: (2022)

Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
por: Ota, Mitsuhito
Publicado: (2022)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
por: Yi, Changhua, et al.
Publicado: (2020)

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
por: Bettini, Emily, et al.
Publicado: (2021)

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
por: Ali, Kashif, et al.
Publicado: (2021)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
por: Echaide, Miriam, et al.
Publicado: (2023)

The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2
por: Jamous, Yahya F, et al.
Publicado: (2023)

Convalescent-anti-SARS-CoV-2-plasma: Anaphylactic shock and transfusion reaction: case report
Publicado: (2020)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions
por: Klingel, Hanna, et al.
Publicado: (2023)

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
por: Widge, Alicia T., et al.
Publicado: (2020)

Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva
por: Ketas, Thomas J., et al.
Publicado: (2021)

Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach
por: Ahammad, Ishtiaque, et al.
Publicado: (2020)

Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva
por: Ketas, Thomas J., et al.
Publicado: (2021)

Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines
por: Stehlin, Florian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_99g9ortcc9m9su4jfl9rq0m8b4